PRESS RELEASE published on 06/07/2024 at 17:45, 10 months 14 days ago Modification des droits attachés aux catégories d'actions Déclaration du nombre de droits de vote et d'actions de Median Technologies au 31 mai 2024. Découvrez les chiffres clés de l'entreprise et ses activités dans l'imagerie médicale et l'IA Euronext Growth Imagerie Médicale Intelligence Artificielle Oncologie Median Technologies
PRESS RELEASE published on 06/07/2024 at 17:45, 10 months 14 days ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and share capital as of May 31, 2024, in compliance with French regulations. The company specializes in AI-driven solutions for cancer diagnosis and treatment Share Capital Voting Rights AI Solutions Median Technologies Cancer Diagnosis
BRIEF published on 05/29/2024 at 17:50, 10 months 23 days ago Median Technologies participera à la réunion annuelle de l'ASCO 2024 à Chicago Solutions D'imagerie Essais Cliniques Oncologie Technologies Médianes Réunion Annuelle De L'ASCO
BRIEF published on 05/29/2024 at 17:50, 10 months 23 days ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
PRESS RELEASE published on 05/29/2024 at 17:45, 10 months 23 days ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 11 months ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
BRIEF published on 05/21/2024 at 17:50, 11 months ago Median Technologies renforce sa position auprès des géants pharmaceutiques Imagerie Médicale Intelligence Artificielle Essais Cliniques Oncologie Median Technologies
PRESS RELEASE published on 05/21/2024 at 17:45, 11 months ago Informations privilégiées / Autres communiqués Median Technologies devient fournisseur privilégié d'un nouveau laboratoire pharmaceutique du Top 3 mondial, renforçant ainsi sa position de leader en services d'imagerie pour les essais cliniques en oncologie Oncologie Median Technologies Laboratoire Pharmaceutique Services D'imagerie Accord-cadre De Services
BRIEF published on 05/10/2024 at 17:50, 11 months 11 days ago Median Technologies annonce une mise à jour sur les droits de vote des actions Droit De Vote Technologies Médianes Structure De Partage Droit Des Sociétés Français Actions Sans Droit De Vote
BRIEF published on 05/10/2024 at 17:50, 11 months 11 days ago Median Technologies Announces Update on Shares Voting Rights Voting Rights Median Technologies Share Structure French Corporate Law Non-voting Shares
Published on 04/22/2025 at 13:30, 38 minutes ago Avant Brands Announces its Annual General and Special Meeting of Shareholders
Published on 04/22/2025 at 13:25, 43 minutes ago Bausch Health Announces Filing of Supplement to Proxy Statement
Published on 04/22/2025 at 13:00, 1 hour 8 minutes ago Yes, We Prove It. Unmistakably Ours: How SMX Is Digitizing the Soul of European Craftsmanship
Published on 04/22/2025 at 13:00, 1 hour 8 minutes ago AIML Innovations Appoints Jared Adelstein to Board of Directors
Published on 04/22/2025 at 13:00, 1 hour 8 minutes ago McFarlane Lake Intersects 6.2 Grams per Tonne (g/t) Gold Over 6.45 Metres (M) Within 14.9 m of 3.0 g/t Gold and Discovers New Mineralized Zones at Depth Containing Visible Gold - Assays Pending
Published on 04/22/2025 at 12:00, 2 hours 8 minutes ago S&P Global Selects Linde for Sustainability Yearbook 2025
Published on 04/22/2025 at 10:00, 4 hours 7 minutes ago Original-Research: Cenit AG (von GBC AG): BUY
Published on 04/22/2025 at 09:40, 4 hours 28 minutes ago EQS-Adhoc: naoo AG: Former Google Switzerland Executive to Drive naoo’s Growth Across German-Speaking Europe
Published on 04/22/2025 at 09:00, 5 hours 8 minutes ago Generali Investments launches Private Credit Secondaries Fund with Partners Group
Published on 04/22/2025 at 10:00, 4 hours 8 minutes ago Descriptif du programme de rachat d'actions autorisé par l'Assemblée générale mixte des actionnaires du 17 avril 2025
Published on 04/22/2025 at 10:00, 4 hours 8 minutes ago Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 17, 2025
Published on 04/22/2025 at 08:30, 5 hours 38 minutes ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 14/04/2025 tot 18/04/2025
Published on 04/22/2025 at 08:30, 5 hours 38 minutes ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 14/04/2025 au 18/04/2025
Published on 04/22/2025 at 08:30, 5 hours 38 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 14/04/2025 to 18/04/2025
